FIELD: chemistry.
SUBSTANCE: invention relates to novel bicyclic heterocyclic derivatives, which are compounds of formula
where values of X1-X5, A, B, R1, R2, q are given in claim 1, as well as pharmaceutical compositions containing said compounds, and use of said compounds to treat cancer.
EFFECT: high efficiency of treatment.
22 cl, 43 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES | 2009 |
|
RU2518089C2 |
| BICYCLIC HETEROCYCLIC COMPOUNDS AS FGFR INHIBITORS | 2007 |
|
RU2466130C2 |
| POLYCYCLIC AGENTS FOR TREATING RESPIRATORY SYNCYTIAL VIRAL INFECTIONS | 2004 |
|
RU2422444C2 |
| PIPERIDINE DERIVATIVES | 2011 |
|
RU2554353C2 |
| PYRASOLE[3,4-b]PYRIDINE COMPOUNDS AND THEIR APPLICATION AS PHOSPHODIESTERASE INHIBITORS | 2003 |
|
RU2348633C2 |
| AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
| THIENOPYRIDINONE COMPOUNDS | 2019 |
|
RU2827549C2 |
| NOVEL COMPOUNDS | 2016 |
|
RU2734256C2 |
| FLUORINATED LIGANDS FOR TARGETING PERIPHERAL BENZODIAZEPINE RECEPTORS | 2007 |
|
RU2468014C2 |
| PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
Authors
Dates
2012-10-27—Published
2007-12-21—Filed